what we need between now and FDA approval is confidence in Philips getting some signed contracts... so that we know in the background they are actually capable of promoting and closing out contract rather than all talk especially when CT:VQ is approved.... this way, between now and FDA approval, if the share price is near the 55c strike price for 4DXOA, we will have a chance to exercise it and provide company up to A$30million funding... since it expires 30days after FDA approval... so Philips will need to prove that the company and us is backing the right horse....
4DX Price at posting:
38.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)